American Herbal Products Association (AHPA) > News > AHPA Reports

AHPA Reports

AHPA's monthly newsletter. Members log in to access issues of the AHPA Report.

March 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The March 2020 AHPA Report includes a discussion of proposals to make supplement regulation more efficient and effective, the Cannabis Committee's 10-year anniversary, AERs and supplement safety, postponed events and an update on international supplement regulation from IADSA.

February 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The February 2020 AHPA Report includes a look at the recent U.S.-China trade agreement, the impact of the Coronavirus on the industry, AHPA's comments to USDA on the domestic hemp product program and the final schedule of AHPA Events at Expo West 2020.

January 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The January 2020 AHPA Report includes class action claims reinstated on “adulterated” supplements, AHPA Events at Expo West 2020, McGuffin named Industry Leader by Nutritional Outlook, and the 2020 Hemp-CBD Supplement Congress.

December 2019 AHPA Report: Looking back at 2019 and forward to 2020

December 2019 AHPA Report: Looking back at 2019 and forward to 2020

AHPA Members, Log in to access the AHPA Report

The December 2019 AHPA Report includes a look back at 2019 and forward to 2020, Class action claims reinstated on “adulterated” supplements, AHPA Events at Expo West 2020, McGuffin named Industry Leader by Nutritional Outlook, and the 2020 Hemp-CBD Supplement Congress.

November 2019 AHPA Report: New Prop 65 Guidance, EPA Crop Group Advocacy, USDA Hemp Rule, Revised FDA Draft Guidance for Homeopathics

November 2019 AHPA Report: New Prop 65 Guidance, EPA Crop Group Advocacy, USDA Hemp Rule, Revised FDA Draft Guidance for Homeopathics

AHPA Members, Log in to access the AHPA Report

The November 2019 AHPA Report includes new CA Prop 65 Guidance, an overview of USDA's rule for hemp, FDA's revised draft guidance for homeopathics, happy birthday DSHEA, McGuffin keynote at HIACON and much more.

October 2019 AHPA Report: Foreign cGMP inspection trends, Prop 65 amendment dropped, CBD advocacy and more

October 2019 AHPA Report: Foreign cGMP inspection trends, Prop 65 amendment dropped, CBD advocacy and more

AHPA Members, Log in to access the AHPA Report

The October 2019 AHPA Report includes recent CBD advocacy, AHPA at IADSA, foreign cGMP inspection trends, nutrition labeling enforcement discretion advocacy, nutrition labeling webinar, AHPA events at SupplySide West and more.

September 2019 AHPA Report: Labeling guidance, GRAS, Glyphosate, AHPA at AOAC and more

September 2019 AHPA Report: Labeling guidance, GRAS, Glyphosate, AHPA at AOAC and more

AHPA Members, Log in to access the AHPA Report

The September 2019 AHPA Report includes guidance on herbal supplement labeling, AHPA at AOAC INTERNATIONAL, climate action in the health and nutrition industry, the glyphosate debate, GRAS: Meeting the burden of persuasion, AHPA at SupplySide West and more.

August 2019 AHPA Report: Data shows supplement recalls are relatively infrequent, insights from the Hemp-CBD Supplement Congress, Prop 65 enforcement data and more

August 2019 AHPA Report: Data shows supplement recalls are relatively infrequent, insights from the Hemp-CBD Supplement Congress, Prop 65 enforcement data and more

AHPA Members, Log in to access the AHPA Report

The August 2019 AHPA Report includes an analysis of FDA recall data, recent CA Prop 65 enforcement trends, the first warning letter addressing FSVP, insights from the Hemp-CBD Supplement Congress and updated guidance for hemp-CBD.

July 2019 AHPA Report: McGuffin celebrates 20 years, CBD Advocacy, IADSA, AHPA in the News and more

AHPA Members, Log in to access the AHPA Report

The July 2019 AHPA Report includes an open letter from AHPA President Michael McGuffin on his 20 years as AHPA President, recent CBD advocacy, AHPA's recommendations for supplement innovation, AHPA email alerts and much more.

June 2019 AHPA Report: FDA-USDA at CBD Congress, NDI-GRAS Workshop, AHPA members and staff at USP, CFSAN, NIH and more

AHPA Members, Log in to access the AHPA Report

The June AHPA Report includes recent AHPA presentations at NIH, USP, CFSAN, plus legal and regulatory updates, recent AHPA news and advocacy and much more.

April-May 2019 AHPA Report: Sustainability for TCM, Annual Report, IADSA, CBD Guidance and more

AHPA Members, Log in to access the AHPA Report

The April-May AHPA Report includes strategies for TCM sustainability, legal and regulatory updates, recent AHPA news and advocacy and much more.

February-March 2019 AHPA Report: AHPA Awards, BOT Election, General Counsel Report to the Board

AHPA Members, Log in to access the AHPA Report

The February-March issue of the AHPA Report features updates and pictures from Expo West, legal and regulatory updates, recent AHPA news and advocacy and much more.

Big Pharma and dietary supplements: barbarians are at the gates in the January 2019 AHPA Report!

January 2019

Developing standardized SOPs and updates on oils, kratom, and facilities registration in the December 2018 AHPA Report!

December 2018 AHPA Report

A look at the 115th and 116th Congresses and the case against mandatory listing of dietary supplement labels in the November 2018 AHPA Report!

November 2018 AHPA Report

RSS
123456789

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.